ID
17493
Description
NCT00428090 / GSK-AVA105640 A 24-week, double-blind, double-dummy, randomized, parallel-group study to investigate the effects of rosiglitazone (extended release tablets), donepezil, and placebo as monotherapy on cognition and overall clinical response in APOE e4-stratified subjects with mild to moderate Alzheimer’s disease. (REFLECT-1) Any untoward medical occurence in a patient or clinical investigation subject, temporally associated with the use of a medicinal product, wether or not considered related to the medicinal product. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of a medicinal product. For marketed medicinal products, this also includes failure to produce expected benefits (i.e. lack of effiacy), abuse or misuse. Examples of an AE includes: - Significant or unexpected worsening or exacerbation of the condition/ indication under study. - Exacerbation of a chronic or intermittent pre-existing condition including either an increase in frequency and/or intensity of the condition. - New condition(s) detected or diagnosed after investigational product administration even though it may have been present prior to the start of the study. - Signs, symptoms, or the clinical sequelae of a suspected interaction. - Signs, symptoms, or the clinical sequelae of a suspected overdose of either investigational product or a concomitant medication (overdose per se should not be reported as an AE/SAE). Examples of an AE does NOT include a/an: - Medical or surgical procedure (e.g. endescopy, appendectomy); the condition that leads to the procedure is an AE. -Situations where an untoward medical occurence did not occur (social and/or convenience admission to a hospital). - Anticipated day-to-day fluctuations of pre-existing disease(s) or condition(s) present or detected at the start of the study that do not worsen. -The disease/disorder being studied, or expected progression, signs, or symptoms of the diseae/disorder being studied, unless more severe than expected for the subject's condition. For GSK clinical studies, AEs may include pre- or post-treatment events that occur as a result of protocol-mandated procedures (i.e., invasive procedures, modification of subject's previous therapeutic regimen). See protocol for clarification. If this event meets the definition of serious, complete the Serious Adverse Event Section.
Mots-clés
Versions (2)
- 18/09/2016 18/09/2016 -
- 25/09/2016 25/09/2016 -
Téléchargé le
18 septembre 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC-ND 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
GSK Non-Serious Adverse Events NCT00428090
GSK Non-Serious Adverse Events NCT00428090
- StudyEvent: ODM
Description
Non-Serious Adverse Events (AE)
Alias
- UMLS CUI-1
- C1518404
Description
Non-Serious Adverse Event
Type de données
text
Alias
- UMLS CUI [1]
- C1518404
Description
Non-Serious Adverse Event Specification
Type de données
text
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C2348235
Description
Start Date
Type de données
date
Unités de mesure
- dd/MMM/yy
Alias
- UMLS CUI [1]
- C0808070
Description
Outcome
Type de données
integer
Alias
- UMLS CUI [1]
- C1705586
Description
End Date
Type de données
date
Unités de mesure
- dd/MMM/yy
Alias
- UMLS CUI [1]
- C0806020
Description
Maximum Intensity
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0518690
- UMLS CUI [1,2]
- C0877248
Description
Action Taken with Investigational Product
Type de données
integer
Alias
- UMLS CUI [1]
- C1704758
Description
Withdrawal
Type de données
boolean
Alias
- UMLS CUI [1]
- C2349954
Description
Relationship to Investigational Product
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0085978
- UMLS CUI [1,2]
- C0877248
Similar models
GSK Non-Serious Adverse Events NCT00428090
- StudyEvent: ODM
C2348235 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,2])